bacteria
singlecel
organ
call
prokaryot
lack
nuclear
membran
usual
mm
length
may
spheric
cocci
rodshap
bacilli
curv
spiralshap
biosafeti
level
level
biocontain
precaut
requir
handl
microorgan
lowest
level
level
concern
organ
typic
danger
level
concern
organ
highli
danger
requir
mani
precaut
work
clinic
microbiolog
hospit
laboratori
perform
epidemiolog
field
studi
involv
incid
distribut
control
diseas
infect
control
practition
public
health
author
track
epidemiolog
multipl
diseas
contain
outbreak
prevent
diseas
fungi
multicel
eukaryot
organ
includ
yeast
mold
dimorph
mold
grow
either
yeast
mold
depend
temperatur
malditof
matrixassist
laser
desorpt
ioniz
timeofflight
mass
spectrometri
method
analyz
biomolecul
laser
fragment
soft
ioniz
within
protect
matrix
follow
measur
spectra
flight
time
vacuum
analyz
primarili
ribosom
protein
microorgan
identifi
speci
level
clinic
laboratori
nextgener
sequenc
method
determin
order
nucleotid
dna
use
highthroughput
technolog
parallel
sequenc
process
produc
mani
sequenc
time
util
varieti
chemistri
signal
detect
method
less
expens
older
sequenc
method
use
produc
larg
quantiti
precis
data
parasit
organ
live
within
anoth
organ
parasit
often
complic
life
cycl
util
intermedi
host
includ
wide
rang
organ
microscop
protozoa
larg
worm
quantit
realtim
polymeras
chain
reaction
variant
polymeras
chain
reaction
use
amplifi
dna
rna
preced
revers
transcriptas
reaction
monitor
amplif
fluoresc
signal
cycl
reaction
compar
signal
standard
curv
determin
quantiti
start
nucleic
acid
virus
submicroscop
infecti
agent
consist
rna
dna
surround
protein
coat
capabl
replic
insid
host
cell
virus
also
lipid
envelop
microb
ubiquit
natur
number
thousand
essenti
health
caus
devast
infecti
diseas
diagnost
microbiolog
must
identifi
pathogen
microb
caus
diseas
distinguish
normal
flora
environment
organ
caus
diseas
diagnost
microbiolog
laboratori
essenti
diagnosi
treatment
infecti
diseas
diagnost
microbiolog
util
method
place
hundr
year
gram
stain
recent
develop
techniqu
allow
sophist
analysi
gene
sequenc
protein
profil
routin
hospit
laboratori
identifi
organ
caus
common
infect
yet
laboratori
personnel
must
also
alert
unusu
pathogen
next
epidem
diagnost
microbiolog
subsect
clinic
patholog
within
hospit
laboratori
usual
part
depart
patholog
depart
laboratori
medicin
microbiolog
laboratori
also
locat
independ
refer
laboratori
serv
larg
geograph
area
offer
broad
test
menu
includ
esoter
test
less
common
infect
director
microbiolog
hospit
clinic
refer
laboratori
may
take
sever
rout
train
director
may
earn
either
md
phd
degre
director
physician
resid
either
patholog
infecti
diseas
common
possibl
addit
medic
microbiolog
fellowship
director
phd
biolog
field
initi
train
fellowship
medic
microbiolog
requir
certif
may
obtain
american
board
patholog
american
academi
microbiolog
depend
train
path
staff
work
hospit
laboratori
may
train
medic
technologist
program
may
receiv
onthejob
train
follow
undergradu
degre
biolog
field
technologistspecif
train
follow
origin
undergradu
degre
certif
technologist
complet
american
societi
clinic
patholog
diseas
caus
microb
diagnost
method
use
detect
microb
vari
wide
base
type
microb
virus
bacteria
fungi
parasit
small
size
virus
nm
depend
host
cell
replic
drive
method
use
detect
virus
typic
carri
dna
rna
surround
protein
shell
virus
lipid
coat
viral
infect
may
acut
chronic
clinic
symptom
viral
infect
may
florid
absent
virus
may
caus
rapid
death
host
cell
integr
viral
genet
materi
host
genom
viral
infect
mild
common
rhinoviru
caus
cold
rare
devast
ebola
viru
caus
hemorrhag
fever
virus
may
highli
contagi
influenza
limit
transmiss
capabl
human
immunodefici
viru
hiv
figur
bacteria
unicellular
organ
lack
nuclear
membran
cell
wall
may
thick
peptidoglycan
layer
thin
peptidoglycan
layer
along
lipidcontain
outer
membran
pathogen
bacteria
mycoplasma
lack
cell
wall
mycobacteria
cell
wall
contain
mycol
acid
properti
affect
virul
stabil
detect
method
fungi
eukaryot
organ
exist
unicellular
yeast
filament
mold
yeast
replic
asexu
wherea
mold
may
replic
sexual
asexu
class
fungi
call
dimorph
fungi
two
form
yeast
form
mold
form
dimorph
mold
histoplasma
blastomyc
coccidioid
promin
pathogen
parasit
eukaryot
microb
vastli
divers
form
protozoa
quit
small
parasit
worm
larg
parasit
complex
life
cycl
evolv
multipl
development
stage
one
two
intermedi
anim
host
infect
definit
host
parasit
diseas
particularli
geographyspecif
know
home
travel
histori
lifestyl
pet
potenti
exposur
patient
requir
part
medic
evalu
creat
parasit
differenti
diagnosi
mani
differ
microorgan
colon
human
organspecif
way
tabl
normal
flora
benefici
us
role
food
metabol
protect
pathogen
microb
product
growth
factor
balanc
interact
innat
adapt
immun
system
environ
import
consid
normal
flora
interpret
result
posit
cultur
normal
flora
rare
pathogen
would
treat
physician
exampl
would
lactobacillu
vagin
specimen
corynebacteria
woundskin
specimen
organ
recov
alway
consid
pathogen
must
treat
exampl
includ
rabi
viru
bacillu
anthraci
plasmodium
listeria
mycobacterium
tuberculosi
third
group
organ
potenti
pathogen
may
colon
individu
group
would
includ
viridan
streptococci
streptococcu
pneumonia
staphylococcu
quit
organ
list
tabl
normal
flora
therefor
essenti
laboratori
result
interpret
context
clinic
scenario
furthermor
mani
environment
microorgan
associ
human
diseas
process
routin
use
clinic
laboratori
tailor
detect
organ
known
caus
diseas
analyz
human
pathogen
essenti
understand
risk
laboratori
profession
cultur
process
sampl
four
biosafeti
level
bsl
increas
precaut
risk
increas
involv
agent
known
caus
diseas
consist
healthi
adult
routin
work
hospit
laboratori
involv
handl
agent
associ
human
diseas
perform
precaut
place
biosafeti
cabinet
physic
contain
devis
use
step
caus
splash
aerosol
person
protect
equip
lab
coat
glove
face
protect
use
need
per
procedur
guidelin
level
guid
test
agent
caus
seriou
diseas
andor
higher
potenti
aerosol
tuberculosi
coccidioid
immiti
increas
protect
obtain
limit
access
room
contain
lab
bench
neg
airflow
laboratori
increas
use
biosafeti
cabinet
increas
step
decontamin
wast
laboratori
much
less
common
deal
danger
agent
hemorrhag
fever
virus
addit
precaut
includ
restrict
access
addit
train
monitor
staff
chang
cloth
posit
pressur
personnel
suit
burden
infecti
diseas
global
enorm
approxim
third
death
global
due
communic
diseas
although
tremend
progress
made
past
centuri
reduc
morbid
mortal
due
infecti
diseas
especi
develop
countri
percentag
death
due
infecti
diseas
compar
mani
type
human
diseas
still
quit
signific
diseas
challeng
us
centuri
tuberculosi
cholera
still
infect
kill
mani
peopl
year
although
worldwid
campaign
erad
diseas
polio
diseas
remain
elimin
caus
human
diseas
longstand
caus
infecti
diseas
remain
preval
new
emerg
infecti
diseas
add
challeng
physician
treat
patient
agent
includ
west
nile
viru
sever
acut
respiratori
syndrom
sar
coronaviru
middl
east
respiratori
syndrom
coronaviru
avian
influenza
viru
hiv
human
metapneumoviru
appear
spread
wide
recent
time
threat
pandem
diseas
occur
larg
geograph
area
real
although
guarante
vigil
public
health
practition
infecti
diseas
specialist
around
world
aid
curtail
next
emerg
diseas
beyond
confirm
associ
infecti
agent
mani
diseas
mani
case
limit
data
associ
specif
diseas
infecti
process
thu
much
ongo
research
attempt
determin
associ
thirti
diseas
evid
suggest
infecti
agent
may
involv
either
agent
identifi
evid
still
preliminari
exampl
includ
crohn
diseas
psoriasi
sarcoidosi
diabet
mellitu
chronic
fatigu
syndrom
atherosclerosi
surpris
mani
find
microb
play
role
sever
malign
previous
thought
infecti
diseas
present
sign
symptom
consist
multipl
noninfecti
diseas
process
posit
microbiolog
result
key
inform
guid
therapi
multipl
dramat
case
patient
undergon
surgeri
treatment
noninfecti
diseas
evalu
malign
unexpectedli
patient
treatabl
infecti
process
effect
commun
primari
treat
physician
infecti
diseas
consult
team
microbiolog
laboratori
staff
help
ensur
correct
test
order
addit
stain
media
ad
need
cover
differenti
diagnosi
furthermor
correct
interpret
data
requir
decid
optim
therapi
test
limit
convey
laboratori
staff
treatment
team
typic
exampl
diseas
associ
specif
bacteria
list
tabl
outbreak
involv
mani
peopl
year
us
public
health
depart
report
foodborn
diseas
outbreak
result
case
ill
hospit
death
step
taken
manag
new
outbreak
includ
detect
outbreak
strain
patient
clinic
microbiolog
laboratori
follow
investig
sourc
infect
virul
suscept
genet
analysi
public
health
research
laboratori
nosocomi
infect
acquir
healthcar
system
common
often
associ
resist
organ
make
therapi
difficult
infect
control
team
healthcar
facil
monitor
nosocomi
infect
adher
isol
guidelin
along
investig
potenti
outbreak
organ
transmiss
within
institut
diagnost
microbiolog
laboratori
perform
test
surveil
transmiss
investig
urinari
tract
infect
common
nosocomi
infect
follow
surgic
wound
respiratori
tract
infect
final
bloodstream
infect
new
hospit
monitor
system
nation
healthcar
safeti
network
requir
hospit
particip
track
nosocomi
infect
track
patient
colon
specif
resist
organ
follow
implement
isol
precaut
hospit
enorm
valu
protect
suscept
vulner
patient
addit
infect
could
spread
throughout
hospit
healthcar
worker
exampl
includ
methicillinresist
staphylococcu
aureu
mrsa
clostridium
difficil
vancomycinresist
enterococcu
respiratori
virus
multidrugresist
gramneg
enterobacteriacea
klebsiella
pneumonia
posit
carbapenemas
enzym
bla
kpc
infect
becom
major
concern
public
health
agenc
gener
public
given
spread
mrsa
recent
year
state
govern
unit
state
establish
legisl
requir
specif
type
monitor
hospit
intens
care
unit
implement
legisl
controversi
mani
physician
felt
although
import
monitor
action
would
best
decid
hospit
infect
control
team
base
data
hospit
instead
legisl
region
govern
without
flexibl
adjust
quickli
chang
need
monitor
infect
trend
chang
flexibl
would
permit
assign
resourc
essenti
area
concern
one
time
mani
countri
guidelin
establish
consensu
committe
infecti
diseas
organ
control
spread
resist
organ
even
specif
legisl
regard
issu
suscept
test
one
critic
function
microbiolog
laboratori
best
use
minim
number
drug
effect
treat
infect
physician
often
start
broadspectrum
drug
empir
therapi
laboratori
data
avail
broadspectrum
antimicrobi
agent
replac
optim
drug
toxic
may
wors
spread
resist
throughout
world
signific
consequ
widespread
use
antibiot
multipl
drug
treat
bacteria
fungi
virus
parasit
develop
sinc
howev
microb
evolv
counter
effect
agent
mani
case
resist
develop
spread
due
mutat
genom
plasmid
small
circular
dna
strand
replic
independ
chromosom
combin
transfer
resist
gene
one
speci
anoth
strain
resist
bacteria
common
methicillinresist
aureu
vancomycinresist
enterococcu
penicillinresist
pneumonia
multidrugresist
organ
resist
avail
antimicrobi
agent
arsen
devast
patient
get
infect
identifi
infecti
agent
caus
set
symptom
patient
may
spare
unnecessari
invas
procedur
diagnos
condit
clearli
accur
diagnosi
respons
infecti
agent
extrem
import
properli
treat
individu
patient
follow
stop
spread
diseas
within
popul
increas
scientif
understand
pathogenesi
old
new
infecti
diseas
stay
uptod
improv
diagnost
assay
advanc
technolog
key
part
job
medic
microbiologist
proper
specimen
collect
essenti
accur
diagnosi
infecti
diseas
correct
specimen
type
must
sent
correct
transport
contain
appropri
temperatur
without
unnecessari
delay
import
issu
constantli
monitor
hospit
laboratori
servic
exampl
common
problem
includ
poorli
collect
urin
specimen
contamin
skinvaginalfec
flora
viral
cultur
collect
viral
transport
medium
contain
antibiot
kill
bacteria
cultur
overgrown
bacteria
failur
collect
infect
wound
tissu
anaerob
transport
media
even
though
anaerob
like
pathogen
case
rna
virus
labil
cultur
posit
would
declin
delay
transport
fortun
viral
test
molecularbas
test
remov
requir
viabl
organ
detect
issu
preval
time
collect
appropri
amount
blood
blood
cultur
potenti
septic
patient
critic
optim
detect
caus
microorgan
improv
test
effect
accredit
organ
colleg
american
pathologist
recent
ad
requir
ongo
monitor
feedback
clinician
blood
volum
collect
patient
improperli
collect
specimen
may
result
miss
diagnosi
altern
report
subsequ
treatment
patient
organ
commens
contamin
along
discontinu
test
true
caus
infect
identifi
appear
new
symptom
patient
collect
specimen
prior
antimicrobi
administr
import
optim
potenti
posit
cultur
especi
true
septic
patient
diagnos
use
blood
cultur
specimen
volum
small
mani
test
request
physician
must
priorit
test
limit
volum
may
adequ
initi
request
set
assay
process
plate
specimen
cultur
done
manual
technologist
howev
autom
system
develop
handl
plate
specimen
three
exampl
autom
system
includ
kiestra
tla
bd
kiestra
bv
drachten
netherland
full
microbiolog
laboratori
autom
fmla
inc
la
balm
franc
wasplab
copan
diagnost
murrieta
ca
high
cost
system
inabl
system
handl
unusu
contain
small
volum
complic
test
panel
result
system
appropri
larg
refer
laboratori
highvolum
laboratori
microscopi
remain
critic
microbiolog
workflow
light
microscopi
fluoresc
microscopi
use
frequent
direct
smear
patient
specimen
permit
detect
infect
without
anteced
cultur
rapid
rout
preliminari
definit
diagnosi
bacteria
divid
gramposit
gramneg
organ
base
histor
stain
use
crystal
violet
safranin
counterstain
distinguish
base
cell
wall
peptidoglycan
thick
membran
lipid
content
tabl
gram
stain
frequent
use
stain
microbiolog
laboratori
figur
mycobacteria
detect
kinyoun
acidfast
stain
fluoresc
stain
figur
calcofluor
white
stain
fungifluor
fluoresc
stain
direct
specimen
frequent
use
detect
fungal
element
exampl
fungal
stain
shown
figur
multipl
fluoresc
stain
util
specif
identif
viral
parasit
organ
incorpor
monoclon
antibodi
specif
iodin
prepar
acidfast
stain
trichrom
stain
use
parasit
identif
exampl
stain
parasit
shown
figur
oil
object
microscop
commonli
use
bacteri
microscopi
dri
object
often
use
wet
mount
fluoresc
stain
dark
field
microscopi
use
illumin
techniqu
enhanc
contrast
unstain
specimen
produc
bright
object
dark
background
use
detect
spirochet
leptospira
routin
use
phase
contrast
microscopi
convert
phase
shift
light
pass
transpar
specimen
bright
chang
visibl
cellular
structur
use
examin
unstain
materi
wet
mount
cell
cultur
laboratori
identif
yeast
mani
case
accomplish
instrument
identifi
bacteria
identif
mold
involv
microscop
analysi
slide
cultur
look
hyphal
element
special
hyphal
structur
call
conidiophor
produc
fungal
spore
call
conidia
requir
time
expertis
lab
begun
use
mass
spectrometri
identif
fungi
greatli
reduc
time
increas
accuraci
identif
burden
diseas
due
parasit
vari
tremend
base
geograph
locat
much
higher
burden
develop
countri
parasitolog
area
laboratori
still
use
tradit
method
multipl
stain
direct
microscop
examin
sever
multiplex
molecular
panel
develop
includ
organ
giardia
entamoeba
addit
pathogen
bacteria
step
crystal
violet
gramposit
gramneg
step
gram
iodin
step
decolor
alcohol
aceton
step
safranin
red
virus
current
routin
lab
incorpor
molecular
method
parasit
daili
workflow
stool
sampl
examin
iodinestain
wet
mount
perman
stain
fix
specimen
motil
protozoa
may
seen
wet
mount
egg
larva
may
seen
perman
smear
tremend
amount
inform
definit
identif
pathogen
made
direct
examin
stool
figur
microscopi
critic
determin
appropri
specimen
test
examin
sputum
sampl
presenc
neutrophil
rel
squamou
epitheli
cell
indic
appropri
specimen
evalu
potenti
pneumonia
wherea
sampl
mani
squamou
epitheli
cell
indic
contamin
oral
cell
flora
thu
poor
specimen
patient
immunocompromis
may
produc
neutrophil
criteria
appropri
specimen
must
adjust
patient
test
shift
consider
molecular
method
without
microscop
examin
specimen
qualiti
control
measur
remov
mani
case
cultur
techniqu
still
essenti
infecti
diseas
identif
even
huge
increas
molecular
test
pathogen
organ
caus
diseas
must
separ
organ
mix
cultur
preval
one
organ
compar
organ
cultur
use
assess
likelihood
organ
contribut
diseas
molecular
techniqu
substitut
inform
time
enrich
nonselect
media
allow
growth
mani
organ
includ
blood
agar
chocol
agar
thioglycol
broth
tabl
select
media
promot
growth
one
group
organ
inhibit
other
differenti
media
permit
distinct
differ
organ
grow
media
select
differenti
media
includ
macconkey
agar
gramneg
bacteria
permit
distinct
lactosefer
organ
due
pink
color
coloni
special
media
promot
growth
specif
organ
inhibit
organ
cefsulodinirgasannovobiocin
agar
yersinia
obtain
isol
coloni
identif
agar
plate
must
streak
appropri
figur
cultur
bacteria
appropri
temperatur
ga
mixtur
essenti
bacteri
cultur
c
co
organ
may
grow
aerob
oxygen
rich
environ
anaerob
lack
oxygen
environ
may
microaerophil
requir
low
concentr
oxygen
capnophil
requir
higher
co
concentr
optim
growth
fungal
cultur
medium
contain
antibacteri
compound
inhibit
bacteri
growth
plate
cultur
c
mycobacteria
cultur
requir
special
media
long
incub
time
week
compar
short
incub
time
h
mani
bacteri
cultur
exampl
variou
coloni
morpholog
differ
type
media
shown
figur
autom
instrument
use
monitor
blood
inocul
broth
blood
cultur
bactec
system
becton
dickinson
spark
md
measur
co
produc
grow
organ
fluoresc
signal
vial
increas
respons
increas
co
continu
monitor
signal
presenc
alarm
bottl
posit
result
much
rapid
detect
sepsi
day
prior
instrument
bactalert
durham
nc
sensor
respons
chang
co
result
color
chang
detect
instrument
virus
either
dna
rna
enclos
protein
coat
without
lipid
membran
shell
virus
requir
host
cell
replic
mani
limit
surviv
outsid
host
tradit
detect
viral
infect
involv
cultur
virus
mammalian
cell
virus
often
display
cell
tropism
preferenti
growth
specif
cell
type
produc
characterist
cytopath
cellular
disrupt
effect
figur
adapt
viral
cultur
shellvial
cultur
specimen
centrifug
cell
grow
coverslip
day
incub
coverslip
stain
fluoresc
label
monoclon
antibodi
specif
viru
question
although
viral
cultur
method
disappear
mani
routin
laboratori
viral
cultur
techniqu
essenti
public
health
epidemiolog
data
collect
vaccin
develop
research
respons
emerg
virus
sever
pathogen
difficult
cultur
noncultivat
clinic
laboratori
includ
treponema
rickettsia
ehrlichia
mani
parasit
epsteinbarr
viru
noroviru
human
papillomavirus
among
other
altern
method
serolog
molecular
techniqu
must
use
identifi
infect
exampl
virusdiseas
associ
list
figur
organ
identifi
phenotyp
base
observ
detect
characterist
morpholog
stain
properti
growth
properti
nutrit
requir
antigen
properti
resist
profil
coloni
morpholog
plate
provid
lot
inform
experienc
microbiologist
coloni
characterist
consid
includ
color
size
shape
whether
coloni
convex
concav
edg
uniform
wrinkl
coloni
pit
agar
hemolysi
blood
plate
coloni
may
glisten
mucoid
dri
opaqu
transpar
exampl
includ
strong
hemolysi
streptococcu
pyogen
pit
agar
eikenella
wrinkl
coloni
pseudomona
stutzeri
specif
organ
may
also
characterist
smell
due
chemic
releas
organ
eikenella
smell
like
bleach
streptococci
smell
like
butter
pseudomona
aeruginosa
smell
like
grape
microbiolog
laboratori
still
perform
number
rapid
biochem
reaction
bacteri
isol
narrow
differenti
diagnosi
quickli
exampl
includ
test
oxidas
lpyrroglutamyl
aminopeptidas
catalas
aureu
latex
bead
test
protein
clump
factor
enzym
identifi
molecul
bacteria
detect
minut
use
substrat
provid
visibl
chang
color
chang
bubbl
agglutin
presenc
specif
bacteria
exampl
shown
figur
histor
analysi
metabol
activ
detect
substrat
util
involv
mani
biochem
tube
per
isol
determin
phenotyp
profil
signatur
bacteri
isol
profil
compar
databas
match
unknown
uniqu
speci
profil
later
commerci
system
develop
miniatur
autom
analysi
phenotyp
properti
vitek
phoenix
becton
dickinson
microscan
walkaway
dade
behr
sensititr
trekthermo
scientif
exampl
commerci
system
autom
system
may
includ
fill
unit
inocul
bacteri
solut
mani
well
cartridg
incub
reader
detect
chang
substrat
ph
indic
follow
reaction
comput
modul
make
initi
interpret
data
one
cartridg
may
contain
test
one
organ
organ
typic
profil
report
transmit
directli
medic
record
treat
physician
see
without
intervent
technologist
laboratori
result
avail
h
inocul
softwar
built
profil
match
well
block
transmiss
physician
investig
complet
laboratori
like
addit
followup
test
introduct
mass
spectrometri
routin
clinic
microbiolog
laboratori
revolution
field
matrixassist
laser
desorpt
ioniz
timeofflight
malditof
mass
spectrometri
rapid
reliabl
identif
system
low
reagent
cost
low
labor
time
initi
invest
expens
instrument
softwar
isol
coloni
place
directli
onto
slide
matrix
solut
absorb
energi
laser
target
bacteria
laser
beam
disrupt
bacteria
releas
molecul
variou
size
vacuum
tube
toward
detector
molecul
travel
base
size
charg
ribosom
protein
predomin
compon
analysi
result
spectrum
unknown
patient
isol
compar
profil
mani
bacteria
databas
match
data
provid
identif
genu
speci
updat
comprehens
databas
critic
optim
result
identif
previous
requir
h
sever
day
complet
min
figur
later
flow
immunochromatograph
assay
rapid
easi
perform
figur
perform
minim
train
provid
rapid
result
assay
identifi
bacteri
antigen
urin
pneumonia
legionella
pneumophila
method
detect
infect
rapidli
method
requir
cultur
incub
time
rapid
antigen
assay
also
use
respiratori
virus
influenza
respiratori
syncyti
viru
review
literatur
center
diseas
control
prevent
cdc
shown
low
sensit
test
although
popular
emerg
primari
care
set
rapid
immunoassay
respiratori
virus
use
caution
differ
format
immunoassay
hiv
use
wide
obtain
rapid
diagnosi
hiv
infect
multipl
clinic
set
test
tuberculosi
perform
facil
practic
mycobacteria
cell
wall
includ
mycol
acid
give
differ
stain
properti
featur
util
acidfast
bacilli
stain
kinyoun
auramin
solid
liquid
media
mycobacteria
tailor
nutrient
requir
organ
inhibit
growth
organ
rapidli
grow
mycobacteria
may
detect
routin
bacteri
media
nontuberculosi
mycobacteria
report
caus
human
diseas
much
previous
brothbas
cultur
system
autom
monitor
exist
mycobacteria
analog
blood
cultur
system
dramat
improv
turnaround
time
growth
mycobacteria
speci
take
week
grow
solid
media
polymeras
chain
reaction
pcr
direct
specimen
extract
mycobacteri
isol
dna
pcr
follow
sequenc
use
molecular
probe
malditof
method
use
today
identifi
mycobacteria
altern
much
slower
convent
biochem
test
yeast
identifi
morpholog
characterist
assimil
andor
ferment
carbohydr
yeast
identifi
multipl
type
autom
system
use
bacteria
final
confirm
identif
requir
coloni
characterist
match
organ
report
identifi
mold
tradit
morpholog
studi
asexu
reproduct
characterist
key
import
yeast
mold
identifi
malditof
extrem
rapid
compar
tradit
mold
identif
techniqu
direct
fluoresc
antibodi
dfa
assay
use
diagnos
varicella
zoster
viru
skin
lesion
toxoplasma
gondii
respiratori
specimen
monoclon
antibodi
direct
uniqu
antigen
organ
conjug
fluoresc
marker
seen
fluoresc
microscop
posit
identif
morpholog
organ
cell
must
distinguish
background
artifactu
fluoresc
pcr
assay
avail
often
sensit
dfa
pcr
assay
use
instead
tradit
method
combin
dfa
perform
quickli
inform
still
felt
provid
evid
magnitud
infect
situ
hybrid
pcr
sequenc
use
molecular
techniqu
microbi
identif
increas
dramat
past
decad
still
rapid
rate
introduct
new
revis
method
applic
detect
organ
nucleic
acid
requir
viabl
organ
big
advantag
molecular
method
overal
tend
sensit
specif
fluoresc
situ
hybrid
fish
techniqu
use
tag
nucleic
acid
probe
cultur
fix
tissu
identifi
dna
suspect
organ
figur
pcr
power
method
use
number
way
pcr
use
heatstabl
dna
polymeras
combin
dna
oligom
primer
specif
sequenc
design
amplifi
specif
target
multipl
cycl
heat
denatur
dna
follow
cool
allow
specif
hybrid
primer
extens
synthes
product
polymeras
enzym
result
millionfold
increas
dna
interest
process
complet
sever
hour
shorter
new
fast
instrument
figur
multipl
adapt
pcr
includ
reversetranscript
pcr
includ
initi
step
convert
rna
dna
follow
dna
amplif
realtim
pcr
permit
quantif
start
nucleic
acid
dna
product
measur
cycl
often
fluoresc
dna
probe
amount
signal
cycl
proport
start
materi
figur
realtim
pcr
use
cytomegaloviru
epsteinbarr
viru
bk
jc
polyomavirus
herpesvirus
quit
target
convers
viral
test
viral
cultur
techniqu
molecular
method
huge
impact
test
turnaround
time
viral
cultur
previous
took
day
result
obtain
hour
virolog
test
move
viral
cultur
shellvial
cultur
rapid
immunochromatograph
assay
dfa
assay
realtim
pcr
assay
multiplex
pcr
includ
multipl
primer
set
singl
reaction
number
ingeni
way
separ
detect
signal
specif
pathogen
assay
current
may
target
individu
assay
respiratori
viru
detect
greatli
improv
multiplex
method
compar
cultur
dfa
assay
antigen
detect
singletarget
pcr
assay
dna
sequenc
gene
ribosom
subunit
compon
cellular
protein
synthesi
machin
use
identifi
bacteria
may
identifi
phenotyp
method
describ
earlier
sequenc
ribosom
gene
may
also
use
identif
fungi
mycobacteria
virus
nucleic
acid
probe
use
identifi
tuberculosi
mycobacteria
number
year
probe
chemiluminesc
label
dna
probe
target
ribosom
rna
result
dnarna
hybrid
distinguish
nonhybrid
probe
stabl
dnarna
hybrid
detect
light
produc
chemic
reaction
accuprob
geneprob
still
use
replac
sequenc
malditof
number
laboratori
hybrid
captur
assay
use
detect
human
papillomavirus
neisseria
gonorrhoea
chlamydia
cytomegaloviru
method
involv
signal
amplif
rna
probe
complementari
dna
target
monoclon
antibodi
conjug
report
molecul
may
use
detect
rnadna
hybrid
addit
nucleic
acid
amplif
method
includ
isotherm
method
nucleic
acid
sequencebas
amplif
transcriptionmedi
amplif
rna
reversetranscrib
cdna
rna
copi
synthes
rna
polymeras
loopmedi
amplif
anoth
isotherm
method
develop
number
target
branchedchain
dna
assay
altern
pcr
short
dna
sequenc
complementari
viral
rna
attach
surfac
captur
target
next
second
cdna
ad
attach
branch
chain
dna
subsequ
cycl
signal
amplifi
method
use
sensit
detect
hiv
viral
load
figur
standard
care
diagnosi
treatment
patient
hiv
infect
includ
determin
actual
viral
load
phenotypicgenotyp
determin
like
suscept
antihiv
agent
instrument
hiv
test
approv
food
drug
administr
fda
us
feder
agenc
respons
protect
public
health
standard
report
viral
titer
intern
unit
provid
compar
result
specif
specimen
regardless
world
specimen
test
incorpor
global
qualiti
control
data
analysi
one
signific
challeng
molecular
method
contamin
new
reaction
amplifi
product
previou
reaction
assay
develop
close
system
avoid
problem
laboratori
separ
work
bench
locat
nucleic
acid
extract
new
patient
specimen
postamplif
step
stringent
control
requir
ensur
ongo
qualiti
assay
infect
control
team
hospit
monitor
spread
pathogen
organ
within
hospit
one
patient
anoth
hospit
individu
battl
underli
ill
vulner
sever
complic
nosocomi
infect
similarli
outbreak
organ
commun
track
public
health
lab
determin
sourc
infect
stop
outbreak
possibl
system
investig
clonal
genet
similar
organ
includ
pulsedfield
gel
electrophoresi
pfge
plasmid
profil
multilocu
sequenc
type
mlst
repetitiveel
pcr
genom
sequenc
restrict
fragment
length
polymorph
rflp
base
method
util
variat
dna
fragment
obtain
upon
specif
restrict
enzym
digest
bacteri
genom
dna
pfge
involv
digest
isol
restrict
enzym
agaros
plug
choos
enzym
result
dna
fragment
dna
separ
special
electrophoresi
devic
use
puls
electr
field
figur
rflp
compar
analyz
multipl
isol
gel
determin
similar
pattern
plasmid
profil
involv
gel
electrophoresi
plasmid
disrupt
genom
dna
discrimin
power
method
variabl
repetitiveel
pcr
amplifi
region
interspers
repetit
dna
element
amplicon
gener
vari
strain
thu
allow
determin
strain
similar
outbreak
mlst
detect
variat
due
mutat
recombin
direct
sequenc
fragment
housekeep
gene
anoth
specif
set
gene
virul
gene
differ
mlst
profil
organ
investig
compar
wholegenom
sequenc
possibl
epidemiolog
tool
decreas
cost
sequenc
entir
genom
compar
singlenucleotid
polymorph
delet
insert
recombin
detect
limit
number
lab
access
wholegenom
sequenc
techniqu
bioinformat
expert
analyz
data
sequenc
also
use
compar
viral
strain
implic
outbreak
serolog
diagnost
techniqu
examin
antibodi
respons
individu
specif
organ
chang
antibodi
titer
specif
microbi
antigen
may
allow
diagnosi
infecti
diseas
would
otherwis
undiagnos
due
lack
posit
cultur
inabl
cultur
organ
due
prior
antimicrobi
therapi
due
lack
altern
assay
would
detect
organ
serolog
use
case
establish
diagnosi
determin
infect
acut
chronic
primari
infect
reinfect
analyz
presenc
immunoglobulin
ig
igg
chang
titer
time
agent
serolog
help
includ
epsteinbarr
viru
hepat
virus
hiv
human
tcell
leukemia
viru
rabi
viru
mycoplasma
pneumonia
arbovirus
serolog
monitor
import
track
success
immun
follow
vaccin
serolog
test
hepat
b
rubella
measl
varicella
zoster
mump
virus
help
document
vaccin
efficaci
choos
appropri
antimicrobi
agent
treatment
patient
infect
suscept
test
laboratori
essenti
empir
therapi
start
time
symptom
definit
diagnosi
establish
caus
pathogen
identifi
usual
broadli
activ
may
unwant
side
effect
may
inact
true
infect
agent
furthermor
widespread
use
broadspectrum
antibiot
contribut
spread
organ
resist
multipl
antibiot
multipl
reason
import
identifi
specif
antimicrobi
therapi
specif
infect
antibacteri
agent
work
variou
mechan
includ
disrupt
cell
wall
synthesi
inhibit
cell
membran
function
inhibit
protein
synthesi
inhibit
dnarna
synthesi
inhibit
metabol
process
differ
organ
develop
variou
mechan
antimicrobi
resist
suscept
test
must
standard
accuraci
method
includ
broth
dilut
agar
dilut
disk
diffus
broth
microdilut
etest
gradient
genotyp
method
variou
method
illustr
figur
organ
incub
presenc
differ
concentr
drug
determin
lowest
concentr
inhibit
growth
organ
thu
determin
minim
inhibitori
concentr
mic
determin
clinic
signific
data
translat
mic
laboratori
inform
physician
use
determin
drug
like
effect
treat
specif
patient
guidelin
establish
clinic
laboratori
standard
institut
suscept
test
method
manual
laborintens
howev
multipl
autom
instrument
develop
test
antimicrobi
suscept
broth
cultur
detect
mic
interpret
mic
expert
softwar
written
check
unusu
pattern
may
indic
error
organ
identif
resist
pattern
signal
multidrugresist
organ
separ
approach
suscept
test
detect
resist
gene
molecular
method
method
much
rapid
phenotyp
test
exampl
common
genotyp
test
includ
meca
gene
use
detect
mrsa
vana
gene
use
detect
vancomycinresist
enterococci
sophist
phenotyp
genotyp
test
hiv
perform
routin
special
laboratori
optim
choic
highli
activ
antiretrovir
therapi
host
factor
organ
infect
influenc
effect
chosen
therapi
patient
symptom
must
monitor
close
therapi
adjust
patient
improv
drug
organ
report
sensit
microbiolog
test
result
must
interpret
context
patient
organ
identifi
specimen
may
pathogen
compon
commens
flora
environment
contamin
underli
condit
patient
strongli
influenc
interpret
laboratori
data
patient
immunocompromis
due
autoimmun
diseas
cancer
chemotherapi
hiv
infect
immunomodul
therapi
genet
disord
result
immunocompromis
like
true
infect
opportunist
pathogen
otherwis
healthi
immunocompet
host
molecular
method
may
detect
dna
nonviabl
organ
detect
low
burden
organ
respons
symptom
patient
interpret
affect
age
patient
newborn
children
adult
differ
pretest
probabl
specif
caus
infect
exampl
mening
newborn
like
due
escherichia
coli
group
b
streptococcu
wherea
mening
older
patient
may
due
neisseria
meningitidi
enteroviru
contamin
cultur
organ
potenti
pathogen
complic
interpret
result
environment
organ
never
report
caus
human
diseas
isol
almost
certainli
contamin
one
would
need
extens
investig
confirm
new
organ
respons
diseas
case
base
coloni
locat
nutrient
agar
plate
easi
determin
isol
laboratori
contamin
case
much
difficult
contamin
must
kept
absolut
minimum
strict
steril
techniqu
process
work
cultur
anoth
import
featur
interpret
may
quantiti
organ
specimen
small
amount
potenti
pathogen
cultur
mix
multipl
bacteria
may
suggest
organ
colon
wherea
heavi
growth
singl
organ
type
like
pathogen
urin
cultur
exampl
routin
quantit
cultur
interpret
base
mixtur
quantiti
organ
present
case
lower
respiratori
tract
wound
cultur
may
quantit
essenti
know
list
normal
flora
specimen
sourc
interpret
result
identif
organ
steril
site
almost
alway
signific
except
contamin
specimen
phenotyp
method
alway
possibl
identifi
organ
absolut
certainti
lab
may
report
result
consist
organ
x
occur
partli
everi
organ
specif
speci
may
give
enzymat
result
one
test
likewis
sequenc
malditof
result
data
may
adequ
distinguish
sever
speci
sever
possibl
organ
may
report
specimen
cultur
clinic
lab
result
often
avail
seri
step
direct
gram
stain
known
immedi
isol
grown
cultur
may
evid
h
longer
cultur
might
sever
microorgan
evid
differ
day
treat
physician
receiv
preliminari
report
follow
updat
becom
avail
clinician
aid
clinic
microbiologist
must
creat
differenti
diagnosi
includ
list
organ
fit
data
date
treat
patient
antimicrobi
cover
possibl
organ
must
weigh
risk
benefit
narrow
therapi
given
time
balanc
neg
aspect
toxic
sever
broadspectrum
agent
benefit
cover
possibl
like
pathogen
cultur
result
final
sever
ill
patient
greatli
impact
decis
typic
posit
blood
cultur
due
contamin
collect
process
sever
factor
use
assess
clinic
signific
posit
blood
cultur
organ
identif
skin
flora
frequent
contamin
wherea
organ
rare
contamin
one
posit
blood
cultur
organ
increas
likelihood
true
posit
find
bacteremia
bacteria
blood
may
caus
diseas
oppos
falseposit
result
growth
organ
blood
anoth
steril
potenti
infect
site
patient
indic
like
bacteremia
diseas
corynebacterium
speci
bacillu
speci
propionibacterium
speci
often
contamin
isol
aureu
e
coli
enterobacteriacea
p
aeruginosa
pneumonia
candida
albican
blood
cultur
almost
alway
clinic
signific
neg
result
microbiolog
cultur
pcr
assay
fluoresc
antibodi
assay
detect
method
could
mean
patient
infect
organ
specimen
inadequ
assay
sensit
enough
organ
much
harder
cultur
other
detect
altern
method
antigen
detect
special
stain
serolog
test
situat
multipl
assay
use
simultan
rule
infect
cultur
multipl
site
combin
molecular
assay
combin
serolog
test
cost
consider
would
favor
limit
test
appropri
number
test
need
given
patient
likewis
assay
number
falseposit
result
result
must
consid
clinic
context
caution
must
use
interpret
quantit
molecular
result
viral
load
mani
test
use
clinic
laboratori
avail
fdaapprov
assay
result
standard
although
laboratori
requir
perform
extens
valid
assay
hiv
viral
load
test
standard
mani
viral
assay
develop
inhous
specif
laboratori
fdaapprov
viral
load
cytomegaloviru
epsteinbarr
viru
adenoviru
often
follow
time
transplant
patient
comparison
viral
load
time
singl
patient
done
data
singl
accredit
laboratori
howev
result
one
laboratori
compar
result
second
laboratori
determin
viral
load
increas
decreas
unless
result
standard
laboratori
otherwis
physician
may
mistakenli
determin
viral
load
chang
better
wors
although
gram
stain
use
daili
laboratori
provid
inform
rapidli
judgment
requir
report
result
limit
assay
due
variat
organ
stain
characterist
exampl
acinetobact
gramneg
coccobacillu
mistaken
gramneg
coccu
neisseria
gramposit
coccu
streptococcu
anaerob
gramposit
organ
frequent
stain
gramneg
organ
singl
organ
type
may
variat
shape
appear
diplococcu
also
elong
coccu
resembl
short
bacillu
slide
lead
microbiologist
mistakenli
interpret
slide
mixtur
two
organ
common
pitfal
known
commun
laboratori
treat
clinician
appropri
cultur
tradit
gold
standard
detect
microb
caus
infecti
diseas
howev
number
organ
either
fastidi
thu
difficult
cultur
uncultivat
routin
laboratori
exampl
includ
epsteinbarr
viru
treponema
pallidum
rickettsia
human
metapneumoviru
advanc
molecular
technolog
great
valu
area
expand
number
bacteria
virus
detect
howev
molecular
test
alway
distinguish
colon
diseaseassoci
infect
design
primer
probe
molecular
assay
suffici
uniqu
sequenc
data
serolog
discuss
also
assist
diagnosi
organ
grow
test
clinic
lab
optim
human
pathogen
environment
organ
may
grow
bacteria
virus
fungi
known
infect
human
includ
assay
design
emerg
infecti
agent
may
detect
quickli
reason
unlik
mani
chemistri
test
run
immedi
directli
blood
specimen
within
minut
microbiolog
result
often
delay
due
time
requir
grow
organ
isol
organ
cultur
determin
suscept
result
one
approach
reduc
turnaround
time
blood
cultur
use
fish
use
peptid
nucleic
acid
probe
target
specif
microb
rrna
blood
cultur
flag
posit
limit
fish
probe
detect
organ
target
miss
organ
target
select
set
probe
although
faster
tradit
bacteri
identif
system
requir
incub
time
enzymat
carbohydr
util
assay
occur
extra
work
run
fish
perform
test
requir
workflow
cost
consider
prevent
lab
adopt
approach
anoth
rapid
approach
perform
malditof
analysi
directli
extract
materi
posit
blood
cultur
without
wait
isol
specif
organ
signific
note
organ
often
miss
mix
infect
number
rapid
approach
complet
workup
organ
present
blood
cultur
still
requir
posit
outcom
rapid
approach
preliminari
data
provid
clinician
rapid
refin
differenti
diagnosi
possibl
earli
treatment
chang
scientist
continu
work
holi
grail
complet
microorgan
identif
directli
patient
specimen
without
need
cultur
current
detect
maximum
number
organ
routin
clinic
microbiolog
laboratori
use
combin
approach
cultur
serolog
antigen
detect
biomark
detect
molecular
method
microscopi
stain
threshold
defin
interpret
specif
bacteri
isol
sensit
resist
specif
drug
suscept
klebsiella
ceftazidim
base
guidelin
clinic
laboratori
standard
institut
clsi
clsi
consensu
bodi
creat
make
decis
best
avail
data
includ
pharmacokinet
pharmacodynam
data
anim
model
vitro
test
comput
simul
limit
patient
outcom
data
multipl
option
therapi
organ
test
sensit
multipl
drug
method
gener
work
well
organ
resist
mani
drug
best
option
clinic
alway
clear
within
past
sever
year
guidelin
provid
clsi
chang
cutoff
valu
mic
valu
translat
sensit
intermedi
resist
number
organismdrug
combin
fda
approv
microbiolog
equip
independ
clsi
process
result
differ
lab
use
differ
cutoff
base
fdaapprov
instrument
method
use
issu
strongli
highlight
fact
medicin
still
art
scienc
physician
must
incorpor
sign
symptom
test
result
make
best
therapeut
plan
databas
interpret
biochem
reaction
profil
bacteria
dna
sequenc
databas
mass
spectrometri
databas
interpret
proteom
profil
malditof
method
must
updat
routin
laboratori
staff
must
awar
organ
includ
databas
specif
speci
includ
databas
select
therefor
misidentif
result
limit
databas
nomenclatur
also
chang
databas
report
must
updat
accordingli
limit
mani
molecular
assay
involv
amplif
step
possibl
contamin
work
area
patient
sampl
amplifi
product
mani
improv
address
concern
close
tube
autom
instrument
reduc
likelihood
contamin
also
addit
deoxyuridin
triphosph
dutp
instead
thymidin
triphospht
dttp
reaction
mix
combin
use
uracil
dna
glycosylas
prior
amplif
step
benefici
elimin
contamin
amplicon
previou
amplif
final
awar
issu
inclus
neg
control
essenti
keep
problem
minimum
cost
signific
concern
hospit
cost
patient
care
compon
cost
laboratori
test
technolog
advanc
microbiolog
laboratori
abl
test
microb
cost
often
much
higher
tradit
method
cost
common
creat
panel
pathogen
test
molecular
method
one
time
instead
cultur
assay
focu
potenti
pathogen
individu
base
likelihood
presenc
pathogen
panel
may
includ
common
pathogen
along
less
common
pathogen
test
adapt
test
subset
target
creat
challeng
order
clinician
microbiolog
director
provid
best
care
individu
patient
without
lose
sight
budget
limit
facil
overal
hope
continu
research
advanc
technolog
result
new
way
reduc
cost
new
comprehens
assay
without
compromis
qualiti
spectrum
target
nucleic
acid
test
continu
becom
even
extens
util
academ
refer
research
laboratori
continu
develop
assay
detect
microb
current
avail
commerci
market
product
like
increas
avail
use
intern
standard
result
report
compar
intern
unit
implement
unit
number
viral
assay
lag
behind
use
area
coumadin
level
hiv
viral
load
wholegenom
sequenc
analysi
use
investig
sever
outbreak
rapidli
precis
defin
chain
transmiss
outbreak
organ
furthermor
lineag
organ
identifi
mechan
increas
virul
compar
similar
nonoutbreak
strain
determin
power
techniqu
identifi
entir
nucleotid
sequenc
organ
includ
order
magnitud
data
provid
older
method
epidemiolog
analysi
pfge
organ
present
differ
pattern
band
pfge
analysi
genom
analysi
necessari
howev
singl
larg
clonal
strain
present
nation
global
discriminatori
power
detect
subtl
chang
genom
analysi
may
desir
detect
spread
hospit
strain
within
specif
set
patient
patient
routin
lab
yet
equip
bioinformat
expertis
approach
usual
need
approach
routin
work
outsid
outbreak
investig
howev
nottoodist
futur
mani
hospit
infect
control
practition
may
find
approach
feasibl
use
perhap
conjunct
onlin
bioinformat
expertis
exampl
power
current
technolog
illustr
european
outbreak
e
coli
sprout
infect
result
high
percentag
patient
develop
hemolyt
urem
syndrom
result
kidney
failur
death
multipl
research
team
sequenc
genom
new
strain
rapidli
allow
track
outbreak
determin
chang
genet
compon
organ
respons
increas
virul
develop
method
detect
microorgan
directli
patient
specimen
without
need
cultur
one
goal
improv
rapid
diagnost
diagnost
instrument
biosystem
current
evalu
util
multistep
approach
pcr
specif
fungi
follow
hybrid
amplifi
dna
nanoparticl
attach
captur
probe
hybrid
yield
microclust
detect
magnet
reson
initi
report
indic
method
detect
yeast
bloodstream
infect
one
colonyform
unit
per
millilit
time
h
collect
detect
technolog
potenti
greatli
improv
patient
care
rapid
diagnosi
yeast
bloodstream
infect
possibl
infect
technolog
adapt
introduct
mass
spectrometri
clinic
microbiolog
laboratori
revolutionari
chang
way
diagnost
microbiolog
practic
mani
year
phenotyp
appear
organ
select
differenti
agar
plate
along
biochem
assay
detect
carbohydr
util
enzym
within
organ
defin
method
identif
laboratori
adopt
newer
method
phenotyp
biochem
data
becom
much
less
import
mass
spectrometri
method
util
routin
clinic
laboratori
use
bacteria
mycobacteria
fungi
investig
current
explor
method
use
mass
spectrometri
strain
type
suscept
test
work
done
area
yet
shown
enough
discriminatori
power
use
patient
care
pcrelectrospray
ioniz
mass
spectrometri
anoth
technolog
larg
potenti
futur
microbiolog
diagnost
method
capabl
identifi
nearli
human
pathogen
differ
type
without
requir
establish
predesign
panel
candid
microb
test
uniqu
featur
assay
test
presenc
specif
organ
method
combin
pcr
step
mass
spectrometri
timeofflight
analyz
identifi
nucleic
acid
base
composit
pcr
product
produc
multiplex
pcr
reaction
result
nucleotid
sequenc
must
analyz
refer
databas
genom
sequenc
identifi
organ
present
technolog
primarili
use
research
food
test
public
health
surveil
biopharmaceut
test
time
yet
adopt
routin
clinic
microbiolog
laboratori
power
potenti
technolog
yet
clear
practic
issu
cost
workflow
technic
expertis
routin
laboratori
inhibit
adopt
methodolog
mani
laboratori
group
scientist
expertis
genom
analysi
microorgan
creat
collabor
effort
creat
global
microbi
identifi
describ
websit
http
wwwglobalmicrobialidentifierorg
object
collabor
creat
global
system
aggreg
share
mine
translat
genom
data
microorgan
real
time
enabl
direct
link
end
user
academia
industri
govern
eg
clinician
veterinarian
epidemiologist
microbiologist
main
databas
userfriendli
platform
system
may
includ
refer
databas
could
access
singl
clinic
task
simpl
microbiolog
identif
nation
intern
public
health
surveil
outbreak
investig
respons
vision
group
fulfil
speed
simplic
analyz
genom
data
put
new
find
appropri
global
context
improv
dramat
given
dynam
rapidli
evolv
natur
medic
microbiolog
doubt
new
pathogen
identifi
next
year
understand
current
known
microb
along
associ
diseas
therapi
also
chang
dramat
within
time
frame
excit
field
one
requir
constant
vigil
emerg
infecti
diseas
assur
us
ongo
need
profession
develop
new
diagnost
test
newli
identifi
pathogen
implement
routin
test
patient
eas
intern
travel
huge
number
peopl
easili
convert
might
local
region
infecti
diseas
outbreak
global
one
cdc
list
emerg
infecti
diseas
monitor
studi
order
understand
pathogenesi
detect
emerg
new
locat
offer
guidanc
practition
recogn
symptom
contain
possibl
exampl
diseas
emerg
recent
time
includ
illustr
import
follow
fascin
human
diseas
variant
creutzfeldtjakob
diseas
transmiss
spongiform
encephalopathi
caus
transmiss
proteinac
particl
call
prion
first
recogn
diseas
human
believ
due
exposur
bovin
spongiform
encephalopathi
transmit
human
cattl
diseas
quit
rare
frighten
current
cure
avail
idea
pathogen
transmiss
protein
viral
bacteri
similar
previous
known
microb
led
much
controversi
mani
year
much
excel
research
diseas
mechan
extens
drugresist
tuberculosi
form
tuberculosi
caus
mycobacteria
resist
effect
antituberculosi
drug
treatment
quit
prolong
result
consider
side
effect
secondand
thirdlin
drug
use
treat
diseas
diseas
associ
much
higher
mortal
rate
form
tuberculosi
advanc
immunodefici
syndrom
due
hiv
first
clinic
observ
unit
state
scientif
studi
shown
hiv
enter
human
popul
much
earlier
date
thought
jump
speci
barrier
sever
independ
occas
give
rise
three
group
viru
past
sever
decad
mani
million
peopl
die
global
epidem
hiv
howev
amaz
advanc
direct
antivir
drug
diagnost
platform
permit
mani
million
live
year
diseas
sar
caus
coronaviru
spread
two
dozen
countri
infect
peopl
global
outbreak
contain
mortal
diseas
middl
east
respiratori
syndrom
recent
viral
respiratori
ill
due
relat
coronaviru
initi
mortal
investig
work
better
understand
risk
viru
includ
sourc
spread
infect
might
prevent
influenza
virus
adapt
rapidli
everi
year
scientist
design
new
influenza
vaccin
combat
next
wave
virus
avian
influenza
virus
evolv
abil
infect
human
number
occas
avian
influenza
viru
detect
number
year
viru
one
recent
report
exposur
infect
poultri
associ
spread
human
popul
avian
virus
tend
caus
sever
diseas
high
mortal
vigil
monitor
detect
adapt
one
virus
strain
transmit
easili
human
increas
likelihood
pandem
high
prioriti
public
health
agenc
k
pneumonia
produc
enzym
known
carbapenemas
respons
spread
drugresist
gramneg
bacteri
infect
mani
countri
world
case
organ
resist
avail
drug
gramneg
organ
high
mortal
seen
infect
patient
comorbid
strong
infect
control
measur
essenti
organ
spread
contact
environ
incomplet
wash
hand
healthcar
worker
figur
